title: Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia.
authors.affiliation: Hematology Unit, University Hospital La Paz-IdiPAZ, Madrid, Spain.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Álvarez Román
authors.forename: Ihosvany
authors.initials: I
authors.lastname: Fernández Bello
authors.forename: Elena G
authors.initials: EG
authors.lastname: Arias-Salgado
authors.forename: Raquel
authors.initials: R
authors.lastname: de Paz
authors.forename: Victor
authors.initials: V
authors.lastname: Jiménez Yuste
authors.forename: Monica
authors.initials: M
authors.lastname: Martín Salces
authors.forename: Nora V
authors.initials: NV
authors.lastname: Butta
mesh_terms: D000368:Aged; D001565:Benzoates / Q000627:therapeutic use*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000503:physiopathology; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000503:physiopathology; D011720:Pyrazoles / Q000627:therapeutic use*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D013926:Thrombopoietin / Q000627:therapeutic use*; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000097:blood
chemical_list: D001565:Benzoates; D006834:Hydrazines; D016756:Immunoglobulins, Intravenous; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag